Drug Prices: A Dysfunctional Market Limits Patient Access
A convoluted, confusing, and opaque system for pricing drugs has evolved that distorts the market and often limits patient access to the drugs they need to survive. In this episode, three experts explain how the system works—or doesn’t’—and the consequences of a dysfunctional pricing system.
I AM BIO · Dan Durham, Anna Hyde, Dr. Vinay Rathi, Theresa Brady
Audio is streamed directly from the publisher (chtbl.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A convoluted, confusing, and opaque system for pricing drugs has evolved that distorts the market and often limits patient access to the drugs they need to survive. In this episode, three experts explain how the system works—or doesn’t’—and the consequences of a dysfunctional pricing system.
Guests:
- Dan Durham, Senior Health Policy Advisor, Biotechnology Innovation Organization
- Anna Hyde, Vice President, Advocacy and Access, Arthritis Foundation
- Dr. Vinay Rathi, Resident Physician, Otolaryngology, Massachusetts Eye and Ear and Mass General Brigham